Log In
Print this Print this

Biosimilar betaseron (PF530)

  Manage Alerts
Collapse Summary General Information
Company Pfenex Inc.
DescriptionBiosimilar of betaseron, an interferon (IFN) beta-1b
Molecular Target Interferon (IFN) beta
Mechanism of ActionBiosimilar
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase I
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat relapsing-remitting (RR) and secondary-progessive multiple sclerosis (MS)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today